论文部分内容阅读
目的探讨糖尿病肾病诊断中血清β_2微球蛋白检验的应用价值。方法选取52例糖尿病肾病患者纳入研究组,另选52例同期到本院体检的健康者纳入对照组。两组均采用免疫放射比浊法,测定血清β_2微球蛋白水平,并进行对比。结果研究组血清β_2微球蛋白水平为(5.9±1.1)mg/L,明显高于对照组的(2.1±0.8)mg/L,差异具有统计学意义(t=20.146,P=0.000<0.05)。研究组血清β_2微球蛋白阳性率为88.5%,对照组血清β_2微球蛋白阳性率为3.8%,比较差异具有统计学意义(P<0.05)。结论在糖尿病肾病患者诊断过程中,实施血清β_2微球蛋白检验的效果理想,值得推广应用。
Objective To investigate the diagnostic value of serum β_2 microglobulin in the diagnosis of diabetic nephropathy. Methods Fifty-two patients with diabetic nephropathy were enrolled in the study group, and another 52 healthy people who were checked to our hospital during the same period were included in the control group. Immunoturbidimetry was used to measure the serum β_2 microglobulin levels in both groups and compared. Results The level of β_2 microglobulin in the study group was (5.9 ± 1.1) mg / L, which was significantly higher than that in the control group (2.1 ± 0.8) mg / L, with statistical significance (t = 20.146, P = 0.000 <0.05) . The positive rate of β_2 microglobulin in the study group was 88.5%, while the positive rate of β_2 microglobulin in the control group was 3.8%. The difference was statistically significant (P <0.05). Conclusion In the diagnosis of diabetic nephropathy, the implementation of serum β_2 microglobulin test results are ideal, it is worth promoting the application.